Connect with us

Hi, what are you looking for?

Science

Moderna to Present Five Abstracts at 2025 Metabolism Congress

Moderna, Inc. has announced that it will present five abstracts related to its investigational mRNA therapeutics at the upcoming 2025 International Congress of Inborn Errors of Metabolism (ICIEM). The event is scheduled to take place from September 2-6, 2025, at the Kyoto International Conference Center in Kyoto, Japan.

This presentation marks a significant milestone for Moderna, as it will showcase data for the first time concerning its programs for methylmalonic acidemia (MMA) and Glycogen Storage Disease Type 1a (GSD1a). The accepted abstracts include three oral presentations and two poster presentations, focusing on the company’s advancements in treating propionic acidemia (PA), MMA, and GSD1a.

The inclusion of these presentations highlights Moderna’s ongoing commitment to addressing rare metabolic disorders through innovative therapies. The company’s research aims to provide new treatment options for patients suffering from these complex conditions.

As mRNA technology continues to evolve, Moderna’s work at this congress seeks to engage the scientific community in discussions about the potential applications of mRNA therapeutics in metabolic diseases. The presentations are expected to contribute valuable insights and foster collaborative efforts in the field.

The ICIEM serves as a global platform for experts to share research findings and explore advancements in the understanding and treatment of inborn errors of metabolism. Moderna’s participation underscores the importance of ongoing research and innovation in this area.

Details regarding the specific content of the presentations will be disclosed during the congress, allowing attendees to gain a deeper understanding of the implications of Moderna’s findings for future therapeutic developments.

You May Also Like

Sports

The UFC event in Abu Dhabi on July 26, 2025, featured a record-breaking performance from Steven Nguyen, who achieved an unprecedented feat by knocking...

Lifestyle

Shares of **Amerant Bancorp** (NYSE:AMTB) received an upgrade from Wall Street Zen on March 10, 2024, transitioning from a hold rating to a buy...

Top Stories

UPDATE: Sydney Sweeney’s Baskin-Robbins advertisement is making waves online as backlash intensifies over her recent American Eagle campaign. Just days after critics condemned the...

Entertainment

The upcoming Netflix series, Bon Appétit, Your Majesty, is making headlines due to a significant casting change just ten days before filming commenced. Originally...

Top Stories

BREAKING: The historic Durango-La Plata Aquatic Center, a cornerstone of community recreation since its opening in August 1958, is facing imminent demolition as part...

Entertainment

**Kat Izzo Defends Relationship with Dale Moss Amid Controversy** Kat Izzo, a contestant from the reality series *Bachelor in Paradise*, publicly affirmed her relationship...

Politics

King Charles has reportedly outlined specific conditions that Prince Harry must meet to facilitate a potential reunion with the royal family. Following a discreet...

Top Stories

URGENT UPDATE: Affordable motorcycle helmets under ₹1000 are now available for safety-conscious riders across India. With road safety becoming a pressing issue, these helmets...

Business

An off-Strip casino in Las Vegas has unveiled Nevada’s latest sportsbook, Boomer’s Sports Book, as part of a substantial renovation. The new facility opened...

Sports

The Las Vegas Aces secured a convincing victory over the Los Angeles Sparks, defeating them 89-74 on March 12, 2024, at Crypto.com Arena. This...

Sports

As the 2025 NFL season approaches, fantasy football enthusiasts are gearing up for their drafts, particularly focusing on tight ends. With players like Brock...

Health

The ongoing impact of poverty on children’s health has prompted urgent calls for action from mental health advocacy groups. With a notable rise in...

Copyright © All rights reserved. This website provides general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information presented. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult appropriate experts when needed. We are not responsible for any loss or inconvenience resulting from the use of information on this site.